Documents & Downloads

Bosutinib analog-1

Bosutinib Analog

Bosutinib analog-1 is an oral bioactive analog of Bosutinib, designed to target and inhibit tyrosine kinases involved in the regulation of cell proliferation and survival. Its primary biological activity is directed towards the treatment of leukemia by impeding the growth of cancerous cells responding to tyrosine kinase signaling. This compound is valuable for research applications in the study of leukemia therapies and the development of targeted cancer treatments.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2468737-92-8
Applications	Bosutinib Analog
Formula	C₂₅H₂₇Cl₂N₅O₃
Molecular Weight	516.42
SMILES	N#CC1=CN=C2C=C(C(OC)=CC2=C1NC3=CC(O)=C(C=C3Cl)Cl)OCCCN4CCN(CC4)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.